Shed is a telehealth weight loss clinic offering GLP-1 medications including compounded semaglutide, with optional health coaching and personalized nutrition plans. It targets adults with a BMI of 27 or higher and markets a 10% body weight loss guarantee or money-back promise. The program operates entirely online, with medications shipped to the patient’s home.
Clinical trials on semaglutide (Wegovy 2.4 mg) show an average 15% body weight loss when combined with diet and exercise — compared to 2.4% with lifestyle changes alone. Shed uses compounded semaglutide prepared by partner pharmacies, which is not FDA-approved. The program includes telehealth provider visits, health coaching access, and a care team, with pricing starting at a lower monthly cost than brand-name Wegovy. Over 150,000 members have completed programs with Shed according to the company.
This review covers how Shed works, what medications it offers, who qualifies, how results compare to clinical data, what the program costs, and how it stacks up against competitors like Found and standard GLP-1 prescribing.
What Is Shed Weight Loss?
Shed is a telehealth-based weight loss clinic offering GLP-1 medications, health coaching, and personalized nutrition plans to adults seeking medically supervised weight management. The clinic operates 100% online — no in-person visits required. Patients complete an intake form, consult with a licensed provider, and receive their medications shipped directly to their homes.
Here’s the thing: Shed’s core offering is compounded semaglutide, not brand-name Wegovy or Ozempic. Compounded medications are prepared by partner pharmacies that comply with state regulations, but they are not FDA-approved. Shed states that all partner pharmacies are inspected for safety, quality, and ingredient transparency. Prescriptions are custom-compounded by licensed pharmacists using pharmaceutical-grade ingredients.
The program goes beyond medication. Shed includes health coaching through its Shed Health Coaching Program, which focuses on nutrition, exercise, sleep, and emotional well-being. The company positions medication as a tool that reduces appetite and quiets ‘food noise’ — the constant preoccupation with eating — allowing patients to focus on building lasting lifestyle habits.
What Shed Includes:
- Compounded GLP-1 medications (semaglutide, injectable or lozenge forms)
- Online provider consultation and ongoing telehealth follow-up
- Access to care team and health coaches
- Personalized nutrition plan
- Medication and supplies shipped to home
- 10% body weight loss guarantee or refund
How Does Shed Work?
Shed follows a four-step process: complete an online form, receive a prescription from a licensed provider, have medications shipped to your home, and receive ongoing support through the care team and health coaches. The intake form screens for BMI, health history, and medication eligibility. Not everyone qualifies — medical contraindications for GLP-1 therapy exclude some applicants.
After approval, the personalized health plan is confirmed and medication is shipped, often within days. The Shed Portal serves as the patient’s ongoing management hub for communications, prescription refills, and coaching access. Telehealth follow-up appointments are included in the program subscription.
The coaching component is a central differentiator. Shed Health Coaches guide patients in building habits that complement the medication. The company’s lead dietitian, Roseanne Schnell, emphasizes that GLP-1 medications work best alongside healthy lifestyle habits and are not a ‘magic bullet.’ The coaching program focuses on protein prioritization, hydration, fiber intake, and gut-friendly foods.
Who Qualifies for Shed?
Shed accepts patients who are over 18 with a BMI of 27 or higher — the same threshold used by most telehealth GLP-1 prescribers. Insurance coverage for weight loss medications typically requires a BMI of 30 or higher, or a BMI of 27 or higher with a qualifying comorbidity like hypertension or type 2 diabetes. Shed’s program works with or without insurance.
Not all applicants qualify even if their BMI meets the threshold. GLP-1 medications have contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and pancreatitis. The online consultation screens for these conditions before a prescription is issued.
The program is described as suitable for patients seeking to reduce sugar intake, improve metabolic health, and build sustainable weight loss habits. Shed also offers supplement bundles for metabolic support and options for patients who are weaning off GLP-1 medication and transitioning to natural maintenance strategies.
How Much Weight Can You Lose with Shed?
Shed’s 10% body weight loss guarantee is based on clinical trials of Wegovy (semaglutide 2.4 mg), which show an average weight loss of 15% when combined with diet and exercise versus 2.4% with lifestyle changes alone. Shed uses compounded semaglutide, not brand-name Wegovy. Compounded medications are not subject to the same clinical trials as brand-name drugs, and individual results vary.
The 15% average from Wegovy trials represents results from the STEP trials — rigorous 68-week randomized controlled studies. In those trials, 86.4% of Wegovy users achieved at least 5% weight loss, and 69.1% achieved at least 10%. Shed’s 10% guarantee reflects the lower bound of what most GLP-1-responsive patients achieve, not the average result from controlled trials.
Results depend significantly on adherence, dosing, and lifestyle factors. Shed’s nutrition plan focuses on protein prioritization, which improves body composition outcomes during GLP-1 therapy. Patients who pair semaglutide with structured dietary changes consistently outperform those relying on medication alone in clinical data.
Semaglutide Weight Loss Data (Wegovy Clinical Trials):
| Outcome | Semaglutide 2.4 mg | Placebo |
|---|---|---|
| Average weight loss | 15% | 2.4% |
| Lost 5%+ body weight | 86.4% | 31.5% |
| Lost 10%+ body weight | 69.1% | 12.0% |
| Lost 20%+ body weight | 32.0% | 1.7% |
What Do Shed Customer Reviews Say?
Shed reports over 150,000 members have completed programs, with thousands citing real results in published patient experiences on the company’s website. Customer reviews generally highlight the reduction in ‘food noise,’ ease of the telehealth process, and the support from health coaches as primary positive factors. The medication’s appetite-reducing effect is consistently cited as the most impactful element.
Positive reviews emphasize the convenience of the all-online process, fast shipping of medications, and the practical support from Shed’s care team. Patients report that the combination of reduced appetite from GLP-1 medication and structured nutrition guidance made sustainable eating habits easier to establish than previous attempts without medical support.
Critical reviews, where available, focus on the use of compounded versus brand-name semaglutide, variability in results, and the cost of ongoing subscriptions. Since Shed does not accept insurance for compounded medications in most cases, out-of-pocket costs are a common concern for patients who don’t see results quickly.
Is Shed’s 10% Weight Loss Guarantee Real?
Yes, the guarantee exists. Shed offers a refund if patients do not achieve 10% body weight loss, with full terms outlined in the program’s Terms and Conditions. The 10% threshold is clinically meaningful — losing 10% of body weight reduces risk of type 2 diabetes, hypertension, and cardiovascular disease in overweight adults. This is not an arbitrary marketing number.
The guarantee applies to the personalized GLP-1 weight loss program when followed as directed. Patients who do not adhere to the plan, discontinue medication early, or fail to attend follow-up consultations may not qualify for the refund under the terms. Reading the full Terms and Conditions before enrolling is essential.
The guarantee is a meaningful differentiator in the telehealth GLP-1 market. Most competitors do not offer outcome-based refund policies. Shed’s willingness to back results with a financial guarantee reflects confidence in the program’s efficacy for patients who complete and adhere to the full treatment plan.
What Medications Does Shed Offer?
Shed’s primary medication offering is compounded semaglutide, available as injectable pens and sublingual lozenges — alternatives to brand-name Wegovy and Ozempic that are prepared by partner compounding pharmacies. Semaglutide is the same active ingredient in Wegovy (weight loss FDA-approved) and Ozempic (diabetes FDA-approved). Shed’s compounded version is not independently FDA-approved.
The injectable form follows the same subcutaneous injection protocol as Wegovy — weekly injections with dose titration over months. The lozenge form (sublingual drops) offers a needle-free alternative. The lozenge’s bioavailability differs from injectable semaglutide, and efficacy data specific to lozenges is more limited than the robust injectable trial data.
Shed also offers microdose GLP-1 options — lower-dose formulations designed for patients who want the appetite-modulating benefits with reduced side effect risk. The company describes microdose GLP-1 as suitable for those looking for a gentler introduction to GLP-1 therapy or a maintenance option after completing a full-dose program.
Shed Medication Options:
- Compounded semaglutide — injectable (weekly subcutaneous injection)
- Compounded semaglutide — sublingual lozenges (needle-free)
- Microdose GLP-1 — lower dose option for gradual or maintenance use
- Supplement bundles for metabolic support (non-prescription)
Is Compounded Semaglutide as Effective as Wegovy?
Compounded semaglutide contains the same active ingredient as Wegovy but has not undergone the same rigorous FDA clinical trials, so direct efficacy comparisons are not validated in controlled research. The 15% average weight loss figure Shed cites comes from Wegovy’s STEP trials, not from studies of compounded versions. This distinction matters when setting expectations.
That said, compounding pharmacies that follow USP standards use pharmaceutical-grade semaglutide at the same molecular structure as the brand-name product. Many patients and clinicians report comparable results at significantly lower cost. The key variable is quality assurance at the compounding pharmacy level — which is why Shed emphasizes state-regulated, inspected partners.
FDA guidance on compounded semaglutide has evolved. During the Ozempic and Wegovy shortage periods, compounded versions were more clearly permitted. As supply normalized, regulatory status has shifted. Patients should confirm the current status of compounded GLP-1 availability with Shed at the time of enrollment, as regulations can change.
What Are the Side Effects of Shed’s GLP-1 Medications?
GLP-1 medications including semaglutide most commonly cause nausea, vomiting, diarrhea, constipation, and stomach pain — particularly in the first weeks of treatment during dose titration. These gastrointestinal effects reflect the drug’s mechanism of slowing gastric emptying. They typically diminish as the body adjusts to the medication over 4-8 weeks.
Shed addresses GI side effects proactively through the nutrition plan. Roseanne Schnell, Shed’s lead dietitian, emphasizes that protein prioritization, hydration, and high-fiber foods reduce GI discomfort during GLP-1 treatment. Patients who eat slowly, in smaller portions, and avoid high-fat meals typically tolerate the medication better than those who don’t adjust their eating patterns.
Rare but serious risks include pancreatitis, gallbladder disease, and, in animal studies (not confirmed in humans), thyroid C-cell tumors. Patients with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome must not use semaglutide. Shed’s intake screening identifies these contraindications before prescribing.
Common Side Effects of GLP-1 Medications:
- Nausea (most common, especially early in treatment)
- Diarrhea or constipation
- Stomach pain and cramping
- Reduced appetite (the intended effect)
- Fatigue, particularly at dose increases
- Injection site reactions (for injectable form)
Who Should Avoid Shed’s Program?
Shed’s GLP-1 medications are contraindicated for patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN2), or prior pancreatitis. These are absolute contraindications that disqualify a patient from GLP-1 therapy regardless of BMI or weight loss goals. Shed’s intake screening is designed to catch these conditions.
Patients with active gallbladder disease, a history of severe GI motility disorders, or those who are pregnant or planning pregnancy should not use semaglutide. Diabetic patients on insulin require careful medication management when adding a GLP-1 agonist due to hypoglycemia risk. Shed’s telehealth providers manage these situations during consultation.
Patients seeking instant results without lifestyle commitment are not ideal candidates. Shed’s program design is explicit that GLP-1 medications are tools, not solutions. The company’s messaging emphasizes that real change happens when medication supports a broader transformation in nutrition, exercise, sleep, and emotional health.
How Much Does Shed Cost?
Shed’s all-inclusive weight loss program includes prescribed medications, supplies, shipping, care team access, and telehealth follow-up at a monthly subscription cost that is significantly lower than brand-name Wegovy at $900-$1,300/month. Specific pricing is confirmed at the time of consultation and varies by medication type and dosing protocol. Compounded semaglutide at telehealth clinics like Shed typically starts at $200-$400/month.
Insurance coverage for compounded semaglutide is generally not available, since compounded medications are not FDA-approved. Shed’s program is structured as an out-of-pocket subscription. The company emphasizes that no insurance is required and that costs are a fraction of brand-name GLP-1 options. Supplement bundles and the GLP-1 Boost maintenance option are available as add-ons.
A monthly wellness plan at $49 is offered as a supplementary tier. Some program tiers include health coaching as part of the base subscription; others offer it as an upgrade. Reviewing the specific inclusions of each tier before enrolling ensures the right program match for individual needs and budget.
GLP-1 Program Cost Comparison:
| Program | Est. Monthly Cost | Medication Type | Coaching Included |
|---|---|---|---|
| Shed | ~$200-$400 | Compounded semaglutide | Yes |
| Found | $99-$149 | Various (GLP-1 + other) | Yes |
| Wegovy (brand name) | $900-$1,300 | FDA-approved semaglutide | No |
| Ozempic (off-label) | $900-$1,300 | FDA-approved semaglutide | No |
Is Shed Worth the Cost?
For patients who qualify and respond well to GLP-1 therapy, Shed offers a structured, supported, and significantly more affordable path to semaglutide access than brand-name options — making the cost-to-outcome case genuinely strong for the right candidate. The 10% guarantee adds financial accountability. Patients who don’t hit that threshold get their money back, which shifts some of the outcome risk to Shed.
The value case weakens if a patient doesn’t engage with the coaching component. Patients who treat Shed purely as a medication delivery service and skip the nutrition and lifestyle guidance tend to achieve smaller results and face higher regain risk after stopping. The full program cost only delivers full program value when fully used.
For budget-conscious patients, Found Weight Loss at $99-$149/month is a meaningful alternative. Found includes health coaching and prescribes a broader range of medications. Shed’s differentiation is the 10% guarantee, the lozenge option, and the specific focus on GLP-1 therapy exclusively. Neither program is a substitute for brand-name Wegovy in terms of FDA-backed clinical data.
Shed vs. Found Weight Loss: Which Is Better?
Shed and Found are both online telehealth weight loss programs combining GLP-1 medications with coaching, but Found offers a broader medication portfolio and lower base pricing while Shed differentiates with a 10% body weight loss guarantee and lozenge delivery option. The right choice depends on the patient’s preferences for medication type, pricing, and support structure.
Found Weight Loss was founded in 2019 and offers GLP-1 medications alongside other prescription weight loss drugs. Pricing ranges from $99-$149/month depending on subscription length. Found has received an average rating of 4.64/5 stars in customer reviews, with users praising effectiveness and professional coaching. The main criticism is the absence of 24/7 support and lack of insurance acceptance.
Shed’s advantage is the outcome guarantee, which Found doesn’t offer. Shed’s disadvantage is a higher monthly cost at typical pricing. For patients who want maximum financial protection against non-response, Shed’s guarantee model is a meaningful differentiator. For those prioritizing the lowest monthly cost with comparable support, Found is a credible alternative.
How Does Shed Compare to Other GLP-1 Programs?
Shed It (Dr. B’s program) is another telehealth option offering prescription GLP-1 treatment with unlimited provider support and a holistic wellness approach — distinguishing itself with broader insurance acceptance for those with qualifying BMI and comorbidities. Shed It targets BMI 27+ and includes access to multiple GLP-1 options for insured patients, including brand-name drugs covered by insurance.
Standard direct Ozempic or Wegovy prescribing through a physician costs $900-$1,300/month without insurance. Telehealth programs like Shed, Found, and Shed It offer compounded alternatives at dramatically lower prices. The trade-off is using non-FDA-approved compounded versions rather than the clinically validated brand-name drugs.
The GLP-1 telehealth market is competitive and evolving quickly. Shed’s 150,000+ member base, money-back guarantee, and comprehensive coaching program place it among the more established players. Patients should compare current pricing, medication type, and program structure at enrollment since offerings change with regulatory and supply conditions.
Why Should You Try Eat Proteins?
Our team at Eat Proteins designs evidence-based nutrition plans that maximize weight loss results on GLP-1 programs like Shed by targeting the single most important dietary factor during GLP-1 therapy: protein intake. GLP-1 medications suppress appetite sharply — but reduced caloric intake without adequate protein causes significant muscle loss, slowing metabolism and undermining long-term results.
The good news? High dietary protein preserves lean muscle mass during the caloric restriction that GLP-1 treatment creates. Shed’s own nutrition program emphasizes protein prioritization — and our experts at Eat Proteins take that principle further with structured daily plans calibrated to each patient’s body weight and activity level. Protecting muscle during a GLP-1 program protects your metabolic rate and your long-term results.
GLP-1 programs like Shed produce the best outcomes when medication, coaching, and nutrition work in the same direction. Eat Proteins fills the nutritional precision gap that general coaching programs often leave open. The habits built during your Shed program are what keep the weight off after treatment ends. That’s the plan worth having.
Can Eat Proteins Help You Get More from Shed?
Yes. Pairing a GLP-1 program with a structured high-protein diet preserves lean muscle mass during the deep caloric restriction that semaglutide creates — protecting metabolic rate and preventing the body composition decline that undermines long-term weight maintenance. Semaglutide patients who lose significant lean mass during treatment face a lower resting metabolic rate, making weight regain more likely after stopping. Protein directly prevents this outcome.
Shed’s lead dietitian emphasizes that GLP-1 medications reduce appetite and quiet food noise, creating the space to build better nutrition habits. Eat Proteins structures those habits into a daily protein-first eating plan from day one of treatment. The reduced hunger from semaglutide makes high-protein eating significantly easier to sustain than it would be on any restrictive diet without medication support.
After completing a Shed program, most patients face the transition question: how do I maintain results without the drug? Structured protein-based eating built during the GLP-1 window is the foundation of that answer. Our experts at Eat Proteins design that transition into the plan from the start. The goal isn’t just weight loss during treatment. It’s permanent body composition change.